RESUMO
The anti-proliferative agent hexamethylene bisacetamide (HMBA) belongs to a class of hybrid bipolar compounds developed more than 30 y ago for their ability to induce terminal differentiation of transformed cells. Recently, HMBA has also been shown to trigger HIV transcription from latently infected cells, via a CDK9/HMBA inducible protein-1 dependent process. However, the effect of HMBA on the immune response has not been explored. We observed that pretreatment of human peripheral blood mononuclear cells with HMBA led to a markedly increased production of IL-12 and IFN-γ, but not of TNF-α, IL-6, and IL-8 upon subsequent infection with Burkholderia pseudomallei and Salmonella enterica HMBA treatment was also associated with better intracellular bacterial control. HMBA significantly improved IL-12p70 production from CD14+ monocytes during infection partly via the induction of type I IFN in these cells, which primed an increased transcription of the p35 subunit of IL-12p70 during infection. HMBA also increased early type I IFN transcription in human monocytic and epithelial cell lines, but this was surprisingly independent of its previously reported effects on positive transcription elongation factor b and HMBA inducible protein-1. Instead, the effect of HMBA was downstream of a calcium influx, and required the pattern recognition receptor and adaptor STING but not cGAS. Our work therefore links the STING-IRF3 axis to enhanced IL-12 production and intracellular bacterial control in primary monocytes. This raises the possibility that HMBA or related small molecules may be explored as therapeutic adjuvants to improve disease outcomes during intracellular bacterial infections.
Assuntos
Acetamidas/farmacologia , Adjuvantes Imunológicos , Interferon Tipo I/biossíntese , Leucócitos Mononucleares/efeitos dos fármacos , Leucócitos Mononucleares/microbiologia , Proteínas de Membrana/metabolismo , Acetamidas/uso terapêutico , Burkholderia pseudomallei/efeitos dos fármacos , Burkholderia pseudomallei/imunologia , Linhagem Celular , Células Cultivadas , Citoplasma/imunologia , Citoplasma/microbiologia , Células Epiteliais/efeitos dos fármacos , Células Epiteliais/imunologia , Células Epiteliais/microbiologia , Humanos , Fator Regulador 3 de Interferon/metabolismo , Interferon Tipo I/genética , Interferon Tipo I/imunologia , Interferon gama/biossíntese , Interferon gama/imunologia , Interleucina-12/biossíntese , Interleucina-12/imunologia , Interleucina-6/biossíntese , Interleucina-6/imunologia , Interleucina-8/biossíntese , Interleucina-8/imunologia , Leucócitos Mononucleares/imunologia , Proteínas de Membrana/imunologia , Nucleotidiltransferases/genética , Nucleotidiltransferases/metabolismo , Salmonella enterica/efeitos dos fármacos , Salmonella enterica/imunologia , Transdução de Sinais , Fator de Necrose Tumoral alfa/biossíntese , Fator de Necrose Tumoral alfa/imunologiaRESUMO
The objective of the present study was to determine the effect of the soluble cytoplasmic fraction from Bifidobacterium bifidum DSM 20082 (Bb) lysate on peripheral blood T cells. In peripheral blood mononuclear cells of healthy subjects, cytotoxic activity, proliferation, apoptosis, and up-regulation of CD8 or CD4 molecules in T cells were examined. When peripheral blood mononuclear cells were stimulated with Bb lysate, the main effect was observed in CD8+ cells as a significant increase of CD8 molecules in a dose-dependent manner, and this behavior was observed at 24, 48, and 72 h after stimulation; in contrast, stimulation with Bb lysate showed no effect on the up-regulation of CD4 molecules in T helper cells. Further Bb lysate did not induce proliferation activity in either CD8+ or CD4+ cells. Bb lysate induced activation of CD8+ cytotoxic activity against autologous monocytes. Around 80% of the cells stimulated with Bb lysate were positive to peanut agglutinin (PNA), suggesting that the stimulated CD8+ cells corresponded to activated/effector cellular populations. When apoptosis was determined, there were no differences between stimulated and non-stimulated cells. Our results indicate that Bb lysate is able to increase cytotoxic activity of peripheral CD8+ cells, without affecting lymphocyte survival.
Assuntos
Bifidobacterium/metabolismo , Antígenos CD4/metabolismo , Antígenos CD8/metabolismo , Linfócitos T CD8-Positivos/metabolismo , Apoptose/imunologia , Bifidobacterium/imunologia , Bifidobacterium/ultraestrutura , Antígenos CD4/genética , Antígenos CD4/imunologia , Antígenos CD8/genética , Antígenos CD8/imunologia , Linfócitos T CD8-Positivos/citologia , Linfócitos T CD8-Positivos/imunologia , Fracionamento Celular , Proliferação de Células , Separação Celular , Citoplasma/imunologia , Citoplasma/metabolismo , Citotoxicidade Imunológica/efeitos dos fármacos , Relação Dose-Resposta Imunológica , Citometria de Fluxo , Humanos , Aglutinina de Amendoim/metabolismo , Preparações de Plantas/farmacologiaRESUMO
BACKGROUND: Birch pollen allergens have been implicated as asthma triggers; however, pollen grains are too large to reach the lower airways where asthmatic reactions occur. Respirable-sized particles containing birch pollen allergens have been detected in air filters, especially after rainfall but the source of these particles has remained speculative. OBJECTIVE: To determine the processes by which birch pollen allergens become airborne particles of respirable size with the potential to contribute to airways inflammation. METHODS: Branches with attached male catkins were harvested and placed in a controlled emission chamber. Filtered dry air was passed through the chamber until the anthers opened, then they were humidified for 5 h and air-dried again. Flowers were disturbed by wind generated from a small electric fan. Released particles were counted, measured and collected for immuno-labelling and high-resolution microscopy. RESULTS: Birch pollen remains on the dehisced anther and can rupture in high humidity and moisture. Fresh pollen takes as long as 3 h to rupture in water. Drying winds released an aerosol of particles from catkins. These were fragments of pollen cytoplasm that ranged in size from 30 nm to 4 microm and contained Bet v 1 allergens. CONCLUSION: When highly allergenic birch trees are flowering and exposed to moisture followed by drying winds they can produce particulate aerosols containing pollen allergens. These particles are small enough to deposit in the peripheral airways and have the potential to induce an inflammatory response.
Assuntos
Alérgenos/imunologia , Asma/imunologia , Betula/imunologia , Pólen/imunologia , Citoplasma/imunologia , Humanos , Immunoblotting/métodos , Microscopia Eletrônica/métodos , Tamanho da Partícula , Respiração/imunologiaRESUMO
Many natural components of plant extracts are studied for their beneficial effects for health and particularly on carcinogenesis chemoprevention. In the present study, we investigated the effects of diosgenin on erythroleukemia HEL cells. Our results demonstrated that diosgenin induced G2/M arrest of cell cycle progression through p21 up-regulation in a p53-independent pathway and strong induction of apoptosis in HEL cells. Apoptosis induction was accompanied by an increase in Bax/Bcl-2 ratio, PARP cleavage and DNA fragmentation. Moreover, we showed for the first time that diosgenin provoked a collapse of mitochondrial membrane potential with an increase in intracellular calcium levels. It is well known that [Ca2+]i increase is one of the major activators of cytosolic PLA2. In our study, we demonstrated that diosgenin treatment induced cPLA2 activation through translocation to the cellular membrane. Moreover, arachidonic acid metabolism activation led to cyclooxygenase-2 (COX-2) but not lipoxygenase overexpression. Surprisingly, we observed a COX-2 up-regulation associated with apoptosis induction by diosgenin. These findings suggest that diosgenin has a potential chemopreventive effect; future studies should evaluate the mechanism of COX-2 activation during diosgenin-induced apoptosis in cancer cell lines.
Assuntos
Antineoplásicos/farmacologia , Apoptose , Cálcio/metabolismo , Diosgenina/farmacologia , Neoplasias/metabolismo , Fosfolipases A/metabolismo , Prostaglandina-Endoperóxido Sintases/biossíntese , Ciclo Celular/efeitos dos fármacos , Linhagem Celular Tumoral , Membrana Celular/imunologia , Proliferação de Células/efeitos dos fármacos , Ciclo-Oxigenase 2 , Citoplasma/imunologia , Fragmentação do DNA , Humanos , Potenciais da Membrana/efeitos dos fármacos , Proteínas de Membrana , Mitocôndrias/efeitos dos fármacos , Neoplasias/enzimologia , Fosfolipases A2 , Poli(ADP-Ribose) Polimerases/metabolismo , Proteínas Proto-Oncogênicas c-bcl-2/metabolismo , Proteína Supressora de Tumor p53/biossíntese , Proteína X Associada a bcl-2RESUMO
Killer cell Ig-like receptor (KIR)2DL4 (2DL4, CD158d) was previously described as the only KIR expressed by every human NK cell. It is also structurally atypical among KIRs because it possesses a basic transmembrane residue, which is characteristic of many activating receptors, but also contains a cytoplasmic immunoreceptor tyrosine-based inhibitory motif (ITIM). We expressed epitope-tagged 2DL4 in an NK-like cell line to study receptor function. Three distinct 2DL4 cDNA clones were analyzed: one encoding the "conventional" 2DL4 with the cytoplasmic ITIM (2DL4.1) and two encoding different cytoplasmic truncated forms lacking the ITIM (2DL4.2 and 2DL4(*)). Surprisingly, one truncated receptor (2DL4.2), which is the product of a prevalent human 2DL4 allele, was not expressed on the cell surface, indicating that some individuals may lack functional 2DL4 protein expression. Conversely, both 2DL4.1 and 2DL4(*) were expressed on the cell surface and up-regulated by IL-2. Analysis of primary NK cells with anti-2DL4 mAb confirmed the lack of surface expression in a donor with the 2DL4.2 genotype. Donors with the 2DL4.1 genotype occasionally expressed receptor only on CD56(high) NK cells, although their expression was up-regulated by IL-2. Interestingly, Ab engagement of epitope-tagged 2DL4 triggered rapid and robust IFN-gamma production, but weak redirected cytotoxicity in an NK-like cell line, which was the opposite pattern to that observed upon engagement of another NK cell activating receptor, NKp44. Importantly, both 2DL4.1 and 2DL4(*) exhibited similar activation potential, indicating that the ITIM does not influence 2DL4.1 activating function. The unique activation properties of 2DL4 suggest linkage to a distinct signaling pathway.
Assuntos
Adjuvantes Imunológicos/biossíntese , Adjuvantes Imunológicos/fisiologia , Interferon gama/biossíntese , Interleucina-2/fisiologia , Células Matadoras Naturais/imunologia , Células Matadoras Naturais/metabolismo , Receptores Imunológicos/biossíntese , Receptores Imunológicos/fisiologia , Adjuvantes Imunológicos/genética , Motivos de Aminoácidos/fisiologia , Sequência de Aminoácidos , Linhagem Celular , Membrana Celular/genética , Membrana Celular/imunologia , Membrana Celular/metabolismo , Citoplasma/imunologia , Citoplasma/metabolismo , Fragmentação do DNA/imunologia , Regulação para Baixo/imunologia , Genótipo , Humanos , Interleucina-2/farmacologia , Células Jurkat , Ativação Linfocitária/imunologia , Dados de Sequência Molecular , Receptor 2 Desencadeador da Citotoxicidade Natural , Receptores Imunológicos/genética , Receptores KIR , Receptores KIR2DL4 , Retroviridae/genética , Retroviridae/imunologia , Transdução Genética , Tirosina/metabolismo , Regulação para Cima/imunologia , Receptor fas/fisiologiaRESUMO
The receptor-like protein tyrosine phosphatase CD45 is essential for TCR signal transduction. Substrates of CD45 include the protein tyrosine kinases p56(lck) and p59(fyn), both of which have been shown to be enriched in detergent-insoluble microdomains. Here we find that there is a cholesterol-dependent association between CD45 and the raft-associated protein linker for activation of T cells, suggesting that CD45 and linker for activation of T cells may colocalize in lipid rafts. Consistent with this observation, we find that approximately 5% of total CD45 can be detected in Triton X-100-insoluble buoyant fractions of sucrose gradients, demonstrating that CD45 is not excluded from lipid rafts. Upon stimulation of T cells with anti-CD3, there is a reduction in the amount of CD45 found associating with lipid rafts. Our data suggest that CD45 is present in lipid rafts in T cells before activation, perhaps to activate raft-associated p56(lck), allowing membrane-proximal signaling events to proceed. Furthermore, the reduction in CD45 content of lipid rafts after CD3 stimulation may serve to limit the amounts of activated p56(lck) in rafts and thus possibly the duration of T cell responses.
Assuntos
Proteínas Adaptadoras de Transdução de Sinal , Detergentes , Antígenos Comuns de Leucócito/metabolismo , Microdomínios da Membrana/imunologia , Microdomínios da Membrana/metabolismo , Proteínas de Membrana , Linfócitos T/imunologia , Linfócitos T/metabolismo , beta-Ciclodextrinas , Animais , Proteínas de Transporte/antagonistas & inibidores , Proteínas de Transporte/metabolismo , Movimento Celular/imunologia , Cetomacrogol , Células Clonais , Ciclodextrinas/farmacologia , Citoplasma/imunologia , Citoplasma/metabolismo , Regulação para Baixo/efeitos dos fármacos , Antígenos Comuns de Leucócito/fisiologia , Ativação Linfocitária , Proteína Tirosina Quinase p56(lck) Linfócito-Específica/metabolismo , Microdomínios da Membrana/enzimologia , Microdomínios da Membrana/fisiologia , Camundongos , Camundongos Endogâmicos C57BL , Octoxinol , Fosfoproteínas/antagonistas & inibidores , Fosfoproteínas/metabolismo , Fosforilação , Óleos de Plantas , Polietilenoglicóis , Solubilidade , Linfócitos T/efeitos dos fármacos , Linfócitos T/enzimologia , Células Tumorais Cultivadas , Tirosina/metabolismoRESUMO
In this study we demonstrated that CD4(+) T cells from STAT4(-/-) mice exhibit reduced IL-12R expression and poor IL-12R signaling function. This raised the question of whether activated STAT4 participates in Th1 cell development mainly through its effects on IL-12 signaling. In a first approach to this question we determined the capacity of CD4(+) T cells from STAT4(-/-) bearing an IL-12Rbeta2 chain transgene (and thus capable of normal IL-12R expression and signaling) to undergo Th1 differentiation when stimulated by Con A and APCs. We found that such cells were still unable to exhibit IL-12-mediated IFN-gamma production. In a second approach to this question, we created Th2 cell lines (D10 cells) transfected with STAT4-expressing plasmids with various tyrosine-->phenylalanine mutations and CD4(+) T cell lines from IL-12beta2(-/-) mice infected with retroviruses expressing similarly STAT4 mutations that nevertheless express surface IL-12Rbeta2 chains. We then showed that constructs that were unable to support STAT4 tyrosine phosphorylation (in D10 cells) as a result of mutation were also incapable of supporting IL-12-induced IFN-gamma production (in IL-12Rbeta2(-/-) cells). Thus, by two complementary approaches we demonstrated that activated STAT4 has an essential downstream role in Th1 cell differentiation that is independent of its role in the support of IL-12Rbeta2 chain signaling. This implies that STAT4 is an essential element in the early events of Th1 differentiation.
Assuntos
Proteínas de Ligação a DNA/fisiologia , Interleucina-12/metabolismo , Receptores de Interleucina/biossíntese , Receptores de Interleucina/fisiologia , Transdução de Sinais/imunologia , Células Th1/citologia , Células Th1/imunologia , Transativadores/fisiologia , Animais , Linfócitos T CD4-Positivos/citologia , Linfócitos T CD4-Positivos/imunologia , Linfócitos T CD4-Positivos/metabolismo , Diferenciação Celular/genética , Diferenciação Celular/imunologia , Divisão Celular/genética , Divisão Celular/imunologia , Linhagem Celular , Células Clonais , Citoplasma/imunologia , Citoplasma/metabolismo , Proteínas de Ligação a DNA/deficiência , Proteínas de Ligação a DNA/genética , Proteínas de Ligação a DNA/metabolismo , Regulação da Expressão Gênica/imunologia , Interleucina-12/fisiologia , Camundongos , Camundongos Endogâmicos BALB C , Camundongos Knockout , Camundongos Transgênicos , Fragmentos de Peptídeos/imunologia , Fragmentos de Peptídeos/metabolismo , Fosforilação , Receptores de Interleucina/metabolismo , Receptores de Interleucina-12 , Fator de Transcrição STAT3 , Fator de Transcrição STAT4 , Transdução de Sinais/genética , Células Th1/metabolismo , Transativadores/deficiência , Transativadores/genética , Transativadores/metabolismo , Tirosina/metabolismo , Tirosina/fisiologiaRESUMO
Zygophyllum fabago L. (Zygophyllaceae) can be found in the Middle East, in North Africa and in the arid zones of the Mediterranean region. It easily establishes itself in new regions, and is considered an invasive plant. They undergo ambophilous pollination, as there is a relationship between this type of pollination and its allergenic incidence. A combination of transmission electron microscopy with immunocytochemical methods was used to localize allergenic proteins during hydration and activation processes. Germination was induced in vitro for 1,2,4,6, and 30 min. The activated proteins reacting with antibodies present in human sera from allergenic patients are found in the cytoplasm, intine, exine and exudates from the pollen grains. The activation time plays an important role on the labelling intensity. Labelling of allergenic proteins was abundant at 1 and 2 min of activation, and decreased at 4 and 6 min. The rapid activation and release of the allergenic proteins appears to be the main cause of allergenic activity of Z. fabago pollen grains.
Assuntos
Alérgenos/imunologia , Alérgenos/metabolismo , Proteínas de Plantas/imunologia , Proteínas de Plantas/metabolismo , Plantas/imunologia , Pólen/imunologia , Citoplasma/imunologia , Citoplasma/metabolismo , Citoplasma/ultraestrutura , Imuno-Histoquímica , Membranas Intracelulares/imunologia , Membranas Intracelulares/metabolismo , Membranas Intracelulares/ultraestrutura , Microscopia Eletrônica , Microscopia Eletrônica de Varredura , Organelas/imunologia , Organelas/metabolismo , Organelas/ultraestrutura , Desenvolvimento Vegetal , Plantas/ultraestrutura , Pólen/crescimento & desenvolvimento , Pólen/ultraestrutura , Fatores de TempoRESUMO
CD19 is a coreceptor on B cells that enhances the increase in cytoplasmic calcium and ERK2 activation when coligated with the B cell Ag receptor. Constructs containing point mutations and truncations were expressed in Daudi human B lymphoblastoid cells to systematically determine the requirement for individual CD19 cytoplasmic tyrosines in these responses. Evidence for activity was found for Y330, Y360, and Y421 as well as that previously published for Y391. Precipitates formed with phosphopeptides consisting of CD19 sequences flanking these residues were used to screen for cytoplasmic proteins that mediate signaling. Phosphopeptide Y330 precipitated Grb2 and Sos, whereas phosphopeptides Y391 and Y421 both precipitated Vav and phospholipase C-gamma2. These molecules also were found associated with native CD19. In mapping studies with altered constructs, CD19 Y330 and/or Y360 were necessary for binding Grb2 and Sos. Vav associated with CD19 constitutively in unstimulated cells by a tyrosine-independent mechanism requiring the portion of CD19 encoded by exons 9-12. After B cell Ag receptor stimulation, Vav association was tyrosine-dependent, but binding was influenced by multiple residues. However, when maximally phosphorylated by pervanadate, Y391 and, to a lesser extent, Y421 were sufficient. CD19 Y391 was also both necessary and sufficient for binding phospholipase C-gamma2. Thus, different tyrosines along the CD19 cytoplasmic domain provide scaffolding for the formation of complexes of different signaling molecules.
Assuntos
Proteínas Adaptadoras de Transdução de Sinal , Antígenos CD19/fisiologia , Linfócitos B/imunologia , Proteínas de Ciclo Celular , Ativação Linfocitária/imunologia , Proteínas/metabolismo , Proteínas Proto-Oncogênicas/metabolismo , Proteína Son Of Sevenless de Drosófila/metabolismo , Fosfolipases Tipo C/metabolismo , Tirosina/fisiologia , Adjuvantes Imunológicos/metabolismo , Adjuvantes Imunológicos/fisiologia , Antígenos CD19/genética , Antígenos CD19/metabolismo , Linfócitos B/efeitos dos fármacos , Linfócitos B/enzimologia , Linfócitos B/metabolismo , Sinalização do Cálcio/imunologia , Citoplasma/imunologia , Citoplasma/metabolismo , Éxons , Proteína Adaptadora GRB2 , Humanos , Isoenzimas/metabolismo , Ativação Linfocitária/efeitos dos fármacos , Sistema de Sinalização das MAP Quinases/imunologia , Proteína Quinase 1 Ativada por Mitógeno/fisiologia , Peso Molecular , Mutagênese Sítio-Dirigida , Mapeamento de Peptídeos , Fosfolipase C gama , Fosfopeptídeos/metabolismo , Proteínas Proto-Oncogênicas c-vav , Receptores de Antígenos de Linfócitos B/metabolismo , Receptores de Antígenos de Linfócitos B/fisiologia , Células Tumorais Cultivadas , Tirosina/genética , Tirosina/metabolismo , Vanadatos/farmacologiaRESUMO
BACKGROUND: Recently, a novel family of low-molecular-weight (8-9 kD), two-EF-hand calcium-binding proteins has been described as allergens in plant pollens. Approximately 10% of pollen-allergic patients have IgE antibodies which cross-react with the two-EF-hand allergens in tree, grass and weed pollens. The aim of the present study was to localize Bet v 4, the two-EF-hand allergen from birch, in mature, dry pollen and to study the release of this allergen after hydration of the pollen by immunogold electron microscopy. METHODS: Using completely anhydrous fixation techniques in combination with immunogold electron microscopy, we localized Bet v 4 and, for control purposes, the major birch pollen allergen Bet v 1, in dry birch pollen as well as in pollen grains after different periods of hydration. Parallel with these morphological studies, we monitored the release of Bet v 4 and Bet v 1 into aqueous supernatants of hydrated birch pollen grains by immunoblotting. RESULTS: Bet v 4 was found in the electron-dense cytosol, in particular between the vesicles and cisternae of the endoplasmic reticulum, inside mitochondria and in the vegetative as well as in the generative nucleus. Bet v 1 was localized in similar cellular compartments except for the mitochondria. After 30 s to 1 min of hydration, Bet v 4 migrated into the pollen exine and into the aqueous supernatants. Bet v 1 also moved out of the pollen grain, though not as quickly as Bet v 4. CONCLUSION: Bet v 4 represents an intracellular pollen protein which, following hydration of pollen grains, rapidly migrates to the pollen surface (exine) and is washed out. This behavior explains how Bet v 4, being primarily an intracellular pollen protein, becomes available to sensitize patients.
Assuntos
Proteínas de Ligação ao Cálcio/análise , Proteínas de Plantas , Pólen/química , Alérgenos/análise , Antígenos de Plantas , Reações Cruzadas/imunologia , Citoplasma/imunologia , Retículo Endoplasmático/imunologia , Imuno-Histoquímica , Microscopia Imunoeletrônica/métodos , Mitocôndrias/imunologia , Células Vegetais , Plantas/ultraestrutura , Água/metabolismoRESUMO
Stimulation of CD4(+) helper T lymphocytes by antigen-presenting cells requires the degradation of exogenous antigens into antigenic peptides which associate with major histocompatibility complex (MHC) class II molecules in endosomal or lysosomal compartments. B lymphocytes mediate efficient antigen presentation first by capturing soluble antigens through clonally distributed antigen receptors (BCRs), composed of membrane immunoglobulin (Ig) associated with Ig-alpha/Ig-beta heterodimers which, second, target antigens to MHC class II-containing compartments. We report that antigen internalization and antigen targeting through the BCR or its Ig-alpha-associated subunit to newly synthesized class II lead to the presentation of a large spectrum of T cell epitopes, including some cryptic T cell epitopes. To further characterize the intracellular mechanisms of BCR-mediated antigen presentation, we used two complementary experimental approaches: mutational analysis of the Ig-alpha cytoplasmic tail, and overexpression in B cells of dominant negative syk mutants. Thus, we found that the syk tyrosine kinase, an effector of the BCR signal transduction pathway, is involved in the presentation of peptide- MHC class II complexes through antigen targeting by BCR subunits.
Assuntos
Apresentação de Antígeno , Antígenos CD/fisiologia , Proteínas de Ligação a DNA , Precursores Enzimáticos/fisiologia , Antígenos de Histocompatibilidade Classe II/imunologia , Antígenos de Histocompatibilidade Classe II/metabolismo , Proteínas Tirosina Quinases/fisiologia , Receptores de Antígenos de Linfócitos B/fisiologia , Animais , Antígenos CD/química , Antígenos Virais/metabolismo , Linfócitos B/enzimologia , Linfócitos B/imunologia , Linfócitos B/metabolismo , Bacteriófago lambda/imunologia , Antígenos CD79 , Citoplasma/imunologia , Precursores Enzimáticos/metabolismo , Epitopos de Linfócito T/metabolismo , Peptídeos e Proteínas de Sinalização Intracelular , Ativação Linfocitária , Linfoma de Células B , Camundongos , Proteínas Tirosina Quinases/metabolismo , Ratos , Receptores de Antígenos de Linfócitos B/química , Proteínas Repressoras/imunologia , Quinase Syk , Células Tumorais Cultivadas , Tirosina/fisiologia , Proteínas Virais , Proteínas Virais Reguladoras e AcessóriasRESUMO
Monoclonal antibodies (mAb) that bind to the immunoglobulin CDR3-like region in the D1 domain of the CD4 molecule can inhibit the HIV-1 life cycle in CD4-positive T cells and lymphoblastoid cell lines at the stage of transcription. This antiviral effect requires the integrity of the cytoplasmic tail of CD4 which is known to act as a signal transduction region through its association with the protein tyrosine kinase (PTK) p56lck. In this study, we investigated the putative role of this PTK in transducing inhibitory signals that act on HIV-1 replication after triggering by anti-CDR3-like region antibody treatment of infected T cell lines. CEM (CD4+/p56lck + inducible), MT2 (CD4+/p56lck - repressed), HSB-2 (CD4-/p56lck + constitutively), HSB-2 WTCD4 (CD4+/p56lck + constitutively), HSB-2 CD4.402 (CD4+ truncated form which lacks the cytoplasmic domain/p56lck + constitutively), and HSB-2 CD4mut (CD4+ unable to bind lck/p56lck + constitutively) were exposed to HIV-1 and cultured in medium supplemented with an anti-CDR3-like region-specific antibody or a control anti-CD4 mAb which does not inhibit HIV-1 transcription. We found that CDR3-loop-mediated inhibitory signals are efficiently transduced in CD4-positive cells which demonstrate a constitutive activation of p56lck or in CD4-positive cells lacking p56lck expression. Moreover, inhibitory signals were transduced in HSB-2 CD4mut cells expressing a cell surface CD4 with a double cysteine mutation in its cytoplasmic tail that renders the molecule unable to bind p56lck, but not HSB-2 CD4.402 cells expressing a truncated form of CD4 which lacks the cytoplasmic domain. These results indicate that the p56lck plays no direct role in this process and suggests the existence of another signaling partner for CD4.
Assuntos
Fármacos Anti-HIV/imunologia , Anticorpos Monoclonais/farmacologia , Antígenos CD4/imunologia , Proteína Tirosina Quinase p56(lck) Linfócito-Específica/imunologia , Complexo Receptor-CD3 de Antígeno de Linfócitos T/imunologia , Transdução de Sinais/imunologia , Ativação Transcricional/imunologia , Antígenos CD4/química , Antígenos CD4/genética , Linfócitos T CD4-Positivos/enzimologia , Linfócitos T CD4-Positivos/imunologia , Citoplasma/imunologia , Proteínas de Ligação ao GTP/efeitos dos fármacos , Proteínas de Ligação ao GTP/fisiologia , HIV-1/imunologia , Humanos , Imunofenotipagem , Proteína Tirosina Quinase p56(lck) Linfócito-Específica/química , Proteína Tirosina Quinase p56(lck) Linfócito-Específica/genética , Mutagênese , Ligação Proteica/genética , Estrutura Terciária de Proteína , Transdução de Sinais/efeitos dos fármacos , Células Tumorais Cultivadas , Fatores de Virulência de Bordetella/farmacologia , Replicação Viral/imunologiaRESUMO
One advantage of the use of peripheral blood stem cells (PBSCs) over autologous bone marrow would be a reduced risk of tumor cell contamination. However, the level of neoplastic cells in the PB of multiple myeloma (MM) patients after mobilization protocols is poorly investigated. In this study, we evaluated PB samples from 27 pretreated MM patients after the administration of high dose cyclophosphamide (7 g/m2 or 4 g/m2) and granulocyte-colony stimulating factor for the detection of myeloma cells as well as hematopoietic progenitors. Plasma cells containing intracytoplasmic lg were counted by microscope immunofluorescence after incubation with appropriate antisera directed against light- and heavy-chain lg. Moreover, flow cytometry studies were performed to determine the presence of malignant B-lineage elements by using monoclonal antibodies against the CD19 antigen and the monotypic light chain. Before initiation of PBSC mobilization, circulating plasma cells were detected in all MM patients in a percentage ranging from 0.1% to 1.8% of the mononuclear cell fraction (mean value, 0.7% +/- 0.4% SD). In these patients, a higher absolute number of PB neoplastic cells was detected after chemotherapy and granulocyte colony-stimulating factor. Kinetic analysis showed a pattern of tumor cell mobilization similar to that of normal hematopoietic progenitors with a maximum peak falling within the optimal time period for the collection of PBSCs. The absolute number of plasma cells showed a 10 to 50-fold increase as compared with the baseline value. Apheresis products contained 0.7% +/- 0.2% SD of myeloma cells (range, 0.2% to 2.7%). Twenty-three MM patients were submitted to PBSC collection. In 10 patients, circulating hematopoietic CD34+ cells were highly enriched by avidin-biotin immunoabsorption, were cryopreserved, and used to reconstitute bone marrow function after myeloablative therapy. The median purity of the enriched CD34+ cell population was 89.5% (range, 51% to 94%), with a 75-fold increase as compared with the pretreatment samples. The median overall recovery of CD34+ cells and colony-forming unit-granulocyte-macrophage was 58% (range, 33% to 95%) and 45% (range, 7% to 100%), respectively. Positive selection of CD34+ cells resulted in 2.5- to 3-log depletion of plasma cells and CD19+ B-lineage cells as determined by immunofluorescence studies, although DNA analysis of CDR III region of IgH gene showed the persistence of minimal residual disease in 5 of 6 patient samples studied. Myeloma patients were reinfused with enriched CD34+ cells after myeloablative therapy consisting of total body irradiation (1,000 cGy) and highdose melphalan (140 mg/m2). They received a median of 4 x 10(6) CD34+ cells/kg and showed a rapid reconstitution of hematopoiesis; the median time to 0.5 x 10(9) neutrophils and to 20 and 50 x 10(9) platelets per liter of PB was 10, 11, and 12 days, respectively. These results, as well as other clinically significant parameters, did not significantly differ from those of patients (n = 13) receiving unmanipulated PBSCs after the same pretransplant conditioning regimen. In summary, our data show the concomitant mobilization of tumor cells and hematopoietic progenitors in the PB of MM patients. Positive selection of CD34+ cells reduces the contamination of myeloma cells from the apheresis products up to 3-log and provides a cell suspension capable of restoring a normal hematopoiesis after a total body irradiation-containing conditioning regimen.
Assuntos
Antígenos CD34/análise , Transplante de Células-Tronco Hematopoéticas/métodos , Células-Tronco Hematopoéticas/citologia , Mieloma Múltiplo/terapia , Plasmócitos/citologia , Adulto , Sequência de Bases , Remoção de Componentes Sanguíneos , Separação Celular , Citoplasma/imunologia , Primers do DNA/química , Feminino , Raios gama , Fator Estimulador de Colônias de Granulócitos/uso terapêutico , Hematopoese , Humanos , Imunoglobulinas/metabolismo , Imunofenotipagem , Masculino , Pessoa de Meia-Idade , Dados de Sequência Molecular , Irradiação Corporal TotalRESUMO
Early endosomes are cellular compartments receiving endocytosed material and sorting them for vesicular transport to late endosomes and lysosomes or for recycling to the plasma membrane. We have cloned a human cDNA encoding an evolutionarily conserved 180-kDa protein on early endosomes named EEA1 (Early Endosome Antigen1). EEA1 is associated with early endosomes since it co-localizes by immunofluorescence with the transferrin receptor and with Rab5 but not with Rab7. Immunoelectron microscopy shows that it is associated with tubulovesicular early endosomes containing internalized bovine serum albumin-gold. EEA1 is a hydrophilic peripheral membrane protein present in cytosol and membrane fractions. It partitions in the aqueous phase after Triton X-114 solubilization and is extracted from membranes by 0.3 M NaCl. It is a predominantly alpha-helical protein sharing 17-20% sequence identity with the myosins and contains a calmodulin-binding IQ motif. It is flanked by metal-binding, cysteine "finger" motifs. The COOH-terminal fingers, Cys-X2-Cys-X12-Cys-X2-Cys and Cys-X2-Cys-X16-Cys-X2-Cys, are present within a region that is strikingly homologous with Saccharomyces cerevisiae FAB1 protein required for endocytosis and with Caenorhabditis elegans ZK632. These fingers also show limited conservation with S. cerevisiae VAC1, Vps11, and Vps18p proteins implicated in vacuolar transport. We propose that EEA1 is required for vesicular transport of proteins through early endosomes and that its finger motifs are required for this activity.
Assuntos
Proteínas de Ligação a Calmodulina/genética , Cisteína/metabolismo , Endossomos/metabolismo , Proteínas de Membrana/genética , Proteínas rab de Ligação ao GTP , Células 3T3 , Sequência de Aminoácidos , Animais , Sequência de Bases , Proteínas de Ligação a Calmodulina/metabolismo , Clonagem Molecular , Citoplasma/imunologia , DNA Complementar , Proteínas de Ligação ao GTP/metabolismo , Células HeLa , Humanos , Soros Imunes , Proteínas de Membrana/imunologia , Proteínas de Membrana/metabolismo , Camundongos , Microscopia Imunoeletrônica , Dados de Sequência Molecular , Ligação Proteica , Coelhos , Receptores da Transferrina/metabolismo , Proteínas Recombinantes/genética , Proteínas Recombinantes/imunologia , Proteínas Recombinantes/metabolismo , Homologia de Sequência de Aminoácidos , Proteínas de Transporte Vesicular , Proteínas rab5 de Ligação ao GTP , proteínas de unión al GTP Rab7RESUMO
El síndrome pulmón riñón se caracteriza por hemorragia alveolar severa y glomerulonefritis. Obedece a variadas etiologías, siendo la vasculitis la causa más frecuente. Recientemente se ha establecido que aquellas vasculitis que comprometen a los capilares, alveolares y glomerulares, cursan con síndrome pulmón riñón. Histológicamente se expresan con una inflamación necrotizante de los capilares alveolares y con glomerulonefritis necrotizante y crescéntica en el riñón. El descubrimiento de los ANCA (Antineutrophil Cytoplasmic Antibodies) a permitido mejorar nuestra comprensión del síndrome pulmón riñón. En este artículo se revisa a la luz de los conocimientos actuales, el diagnóstico etiológico de este síndrome. Considerando que las alteraciones histológicas a nivel pulmón son inespecíficas, el diagnóstico etiológico debe realizarse en base a las manifestaciones clinicopatológicas del compromiso extrapulmonar y/o de las alteraciones serológicas características
Assuntos
Humanos , Anticorpos/imunologia , Doença Antimembrana Basal Glomerular/etiologia , Vasculite/complicações , Diagnóstico Clínico , Citoplasma/imunologia , Neutrófilos/imunologia , Doença Antimembrana Basal Glomerular/diagnóstico , Doença Antimembrana Basal Glomerular/fisiopatologia , Doença Antimembrana Basal Glomerular/imunologia , Sinais e Sintomas , Esteroides/uso terapêutico , Vasculite/tratamento farmacológicoRESUMO
Dry and rehydrated birch pollen grains were anhydrously fixed and double immunogold-labeled for the presence of two allergens, Bet v I major allergen (17 KD) and profilin (14 KD). In dry pollen grains, both allergens are found exclusively inside the cytoplasm. In pollen grains rehydrated for 1 min, the cytoplasm is partially devoid of the two allergens, whereas the pollen wall and the germination aperture are specifically labeled. Pollen grains rehydrated for 5 min are largely free of the two allergens. In immunoblot experiments, both allergens could be detected in the aqueous supernatants of rehydrated pollen samples within 5 min. The results obtained by both methods show the high solubility of both proteins. This makes them readily available to the immune system and characterizes them as potent allergens. Moreover, the solubilization of profilin might indicate a dissociation of the profilin-actin complex at the very first stage of pollen germination, which could favor formation of the cytoskeleton and pollen tube growth.
Assuntos
Alérgenos/análise , Proteínas Contráteis , Pólen/química , Citoplasma/química , Citoplasma/imunologia , Imuno-Histoquímica , Proteínas dos Microfilamentos , Microscopia Imunoeletrônica , Pólen/imunologia , Pólen/ultraestrutura , Profilinas , ÁrvoresRESUMO
The simultaneous occurrence of two different lymphomas in a 57-year-old white woman is reported: mycosis fungoides and a leukemic lymphoplasmacytoid immunocytoma. The first was confirmed by histologic study and electron microscopy, and the latter by histologic study and immunoperoxidase staining. The lymphoid cells in the involved bone marrow and peripheral blood expressed the same surface immunoglobulin as was found in the cytoplasm of the immunocytoma cells, i.e., IgM-lambda. The clonal B-cell expansion was brought into a lasting remission by chlorambucil, but the cutaneous lymphoma proved to be refractory to therapy. The patient died 38 months after diagnosis.
Assuntos
Linfoma não Hodgkin/patologia , Micose Fungoide/patologia , Neoplasias Primárias Múltiplas/imunologia , Neoplasias Cutâneas/patologia , Clorambucila/uso terapêutico , Citoplasma/imunologia , Feminino , Testes Hematológicos , Humanos , Imunoglobulina M/análise , Cadeias lambda de Imunoglobulina/análise , Linfonodos/imunologia , Linfonodos/patologia , Linfócitos/imunologia , Linfoma não Hodgkin/tratamento farmacológico , Linfoma não Hodgkin/imunologia , Pessoa de Meia-Idade , Micose Fungoide/tratamento farmacológico , Micose Fungoide/imunologia , Terapia PUVA , Receptores de Antígenos de Linfócitos B/análise , Neoplasias Cutâneas/tratamento farmacológico , Neoplasias Cutâneas/imunologiaAssuntos
Mama/imunologia , Imunoglobulina A/biossíntese , Lactação , Adulto , Células Produtoras de Anticorpos , Mama/anatomia & histologia , Mama/metabolismo , Contagem de Células , Colostro/imunologia , Citoplasma/imunologia , Feminino , Humanos , Imunoglobulina A/análise , Imunoglobulina G/análise , Cadeias J de Imunoglobulina/análise , Imunoglobulina M/análise , Mucosa Intestinal/imunologia , Mucosa Intestinal/metabolismo , Aparelho Lacrimal/imunologia , Aparelho Lacrimal/metabolismo , Tamanho do Órgão , Glândula Parótida/anatomia & histologia , Glândula Parótida/imunologia , Glândula Parótida/metabolismo , GravidezRESUMO
Fischer 344 male rats showed a low average level (less than ++) of in vivo as well as in vitro neuron binding antibody at 3, 15, and 26 months. However, a significant increase with age in average intensity of binding was observed with both the in vivo and the in vitro conditions. If a criterion of ++ is used as an antibody binding level likely to have biological consequences, the percent of in vivo cases showing foci of ++ or greater intensity also rises with age from 20 to 80%; a criterion of +++ gives an in vivo rise with age of only from 10 to 20%. The in vitro incidence with the ++ criterion is already 80% at three months and rises to 90%; with the +++ criterion the incidence with age rises from 20 to 80%. No evidence was obtained to support the concept that there is a weakening of the blood-brain-barrier in 26 month rats either by the systemic injection of trypan blue or by a comparison of intensity of antibody binding between extra- and intra-barrier neurones.
Assuntos
Envelhecimento , Autoanticorpos/análise , Sítios de Ligação de Anticorpos , Citoplasma/imunologia , Neurônios/imunologia , Animais , Proteínas Sanguíneas/análise , Barreira Hematoencefálica , Encéfalo/imunologia , Hipotálamo/imunologia , Técnicas Imunoenzimáticas , Técnicas In Vitro , Masculino , Neurônios/citologia , RatosRESUMO
Toxoplasma gondii tachyzoites were disrupted in a Ribi cell fractionator and separated into cell walls and protoplasm by differential centrifugation. These products were used alone or combined with a mycobacterial glycolipid (P3) and injected either as oil-in-water emulsions or incorporated in Freund's incomplete adjuvant. Mice were vaccinated by intravenous or intradermal routes and challenged intraperitoneally with a highly virulent strain of Toxoplasma gondii. A local granuloma formation was induced after i.d. inoculation of Toxoplasma vaccines containing P3 as this glycolipid enabled an adherence of the antigens on the mineral oil droplets. The adjuvant effect of P3 on antibody formation was also observed. Most of the fractions showed a low, but statistically significant prolongation of survival time. Vaccination by the i.v. route with homologous or heterologous antigens, including Trypanosoma cruzi, were not significantly effective, with the exception of a high dose of Toxoplasma protoplasm associated with P3.